Abstract |
Short-chain fatty acids (SCFAs), metabolites of intestinal microorganisms, have been linked to the occurrence and development of a variety of disorders, including cardiovascular disease (CVD), which is frequently accompanied by a sustaining inflammatory response and aberrant angiogenesis. Accumulating evidence from the study emphasizes that SCFAs are closely connected with the activation of the NLRP3 inflammasome ( NACHT, LRR, and PYD domains-containing protein 3) and the process of angiogenesis. This review summarizes emerging literature on the impact of SCFAs on various physiological processes, with a subtle attention on the interaction between SCFAs and CVD (especially atherosclerosis, myocardial infarction, and hypertension), SCFAs and NLRP3 inflammasome, as well as SCFAs and angiogenesis. As a result, we speculate that it is convincing that SCFAs play a mediating role in the microbiota- inflammasome-angiogenesis-CVD axis, opening up a new horizon to investigate the function or level of SCFAs as a therapeutic strategy for CVD.
|
Authors | Juan Yao, Yu Chen, Ming Xu |
Journal | Clinical immunology (Orlando, Fla.)
(Clin Immunol)
Vol. 238
Pg. 109013
(05 2022)
ISSN: 1521-7035 [Electronic] United States |
PMID | 35436628
(Publication Type: Journal Article, Review, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2022 Elsevier Inc. All rights reserved. |
Chemical References |
- Fatty Acids, Volatile
- Inflammasomes
- NLR Family, Pyrin Domain-Containing 3 Protein
|
Topics |
- Cardiovascular Diseases
- Fatty Acids, Volatile
(metabolism)
- Humans
- Inflammasomes
(metabolism)
- Intestines
- NLR Family, Pyrin Domain-Containing 3 Protein
(metabolism)
|